SpringWorks Therapeutics Inc (NASDAQ: SWTX) started the day on Thursday, with a price increase of 1.75% at $29.11, before settling in for the price of $28.61 at the close. Taking a more long-term approach, SWTX posted a 52-week range of $18.00-$53.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -20.00%. Meanwhile, its Annual Earning per share during the time was -65.72%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 35.57%. This publicly-traded company’s shares outstanding now amounts to $73.49 million, simultaneously with a float of $66.98 million. The organization now has a market capitalization sitting at $2.16 billion. At the time of writing, stock’s 50-day Moving Average stood at $35.09, while the 200-day Moving Average is $40.93.
SpringWorks Therapeutics Inc (SWTX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. SpringWorks Therapeutics Inc’s current insider ownership accounts for 9.82%, in contrast to 99.07% institutional ownership. According to the most recent insider trade that took place on Sep 03 ’24, this organization’s Chief Executive Officer sold 49,000 shares at the rate of 40.57, making the entire transaction reach 1,988,033 in total value, affecting insider ownership by 1,063,368. Preceding that transaction, on Sep 03 ’24, Company’s Chief Operating Officer sold 20,000 for 40.65, making the whole transaction’s value amount to 812,954. This particular insider is now the holder of 229,600 in total.
SpringWorks Therapeutics Inc (SWTX) Earnings and Revenue Records
SpringWorks Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 35.57% and is forecasted to reach -1.82 in the upcoming year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
Let’s observe the current performance indicators for SpringWorks Therapeutics Inc (SWTX). It’s Quick Ratio in the last reported quarter now stands at 7.77. The Stock has managed to achieve an average true range (ATR) of 1.35. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 25.08.
In the same vein, SWTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.28, a figure that is expected to reach -0.75 in the next quarter, and analysts are predicting that it will be -1.82 at the market close of one year from today.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
If we take a close look at the recent performances of SpringWorks Therapeutics Inc (NASDAQ: SWTX), its last 5-days Average volume was 0.71 million that shows plunge from its year to date volume of 0.96 million. During the previous 9 days, stock’s Stochastic %D was recorded 14.44% While, its Average True Range was 1.22.
Raw Stochastic average of SpringWorks Therapeutics Inc (SWTX) in the period of the previous 100 days is set at 5.83%, which indicates a major fall in contrast to 15.03% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 30.13% that was lower than 42.47% volatility it exhibited in the past 100-days period.
